The National Average Retail Price (NARP) Survey, which provides prescription revenue for thousands of brand and generic drugs, was recently cut by CMS. The NARP Survery compiles data that includes, the cost of ingredients, copayment information, as well as dispensing fees.“Effective July 1, 2013, CMS has suspended Part I of the nationwide retail survey for collecting information about consumer purchase prices, pending funding decisions. Therefore, the resulting draft NARP file will not be published on Medicaid.gov at this time; however, archive files will remain on the website.”
How will this impact the data and calculation reporting used to determine rebates for manufacturers? Want to learn more about the future of the NARPs? Join us for the 18th Annual Medicaid Drug Rebate Program, September 9-11 in Chicago, IL. We'll be covering information regarding AMPs, NARPs, and NADACs. To learn more, download our agenda.
As a reader of this blog, you'll receive 15% off the standard rate to register when you use code XP1858BLOG. We look forward to seeing you in September!
1 comment:
This is fantastic!
Post a Comment